Haller H - Search Results

1

Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein binding.

Kielstein JT, Böger RH, Bode-Böger SM, Martens-Lobenhoffer J, Lonnemann G, Frölich JC, Haller H, Fliser D. Kielstein JT, et al. Among authors: haller h. Clin Nephrol. 2004 Oct;62(4):295-300. doi: 10.5414/cnp62295. Clin Nephrol. 2004. PMID: 15524060

2

Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.

Kielstein JT, Bode-Böger SM, Frölich JC, Haller H, Böger RH. Kielstein JT, et al. Among authors: haller h. Kidney Int Suppl. 2001 Feb;78:S9-13. doi: 10.1046/j.1523-1755.2001.59780009.x. Kidney Int Suppl. 2001. PMID: 11168975 Free article. Review.

3

[Nephropathy in type 2 diabetes mellitus].

Fliser D, Haller H. Fliser D, et al. Among authors: haller h. Internist (Berl). 2000 Dec;41(12):1363-73. Internist (Berl). 2000. PMID: 11189071 Review. German. No abstract available.

4

Right-sided chest pain at the onset of haemodialysis.

Kielstein JT, Abou-Rebyeh F, Hafer C, Haller H, Fliser D. Kielstein JT, et al. Among authors: haller h. Nephrol Dial Transplant. 2001 Jul;16(7):1493-5. doi: 10.1093/ndt/16.7.1493. Nephrol Dial Transplant. 2001. PMID: 11427649 No abstract available.

5

Angiotensin II subtype 1-receptor antagonists in the treatment of diabetic nephropathy.

Fliser D, Haller H. Fliser D, et al. Among authors: haller h. J Hypertens Suppl. 2001 Jun;19(1):S57-60. doi: 10.1097/00004872-200106001-00008. J Hypertens Suppl. 2001. PMID: 11451216 Review.

6

ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?

Kielstein JT, Frölich JC, Haller H, Fliser D. Kielstein JT, et al. Among authors: haller h. Nephrol Dial Transplant. 2001 Sep;16(9):1742-5. doi: 10.1093/ndt/16.9.1742. Nephrol Dial Transplant. 2001. PMID: 11522849 Review. No abstract available.

7

Conversion of Goodpasture's syndrome into membranous glomerulonephritis.

Kielstein JT, Helmchen U, Netzer KO, Weber M, Haller H, Floege J. Kielstein JT, et al. Among authors: haller h. Nephrol Dial Transplant. 2001 Oct;16(10):2082-5. doi: 10.1093/ndt/16.10.2082. Nephrol Dial Transplant. 2001. PMID: 11572902 No abstract available.

8

Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.

Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D. Kielstein JT, et al. Among authors: haller h. J Am Soc Nephrol. 2002 Jan;13(1):170-176. doi: 10.1681/ASN.V131170. J Am Soc Nephrol. 2002. PMID: 11752034

9

Haemodialysis, atherosclerosis and inflammation-identifying molecular mechanisms of chronic vascular disease in ESDR patients.

Walter R, Mischak H, Haller H. Walter R, et al. Among authors: haller h. Nephrol Dial Transplant. 2002;17 Suppl 3:24-9. doi: 10.1093/ndt/17.suppl_3.24. Nephrol Dial Transplant. 2002. PMID: 11912296 Review. No abstract available.

10

An uncommon cause of metabolic acidosis in a haemodialysis patient.

Woywodt A, Kielstein JT, Haller H. Woywodt A, et al. Among authors: haller h. Nephrol Dial Transplant. 2002 May;17(5):929-30. doi: 10.1093/ndt/17.5.929. Nephrol Dial Transplant. 2002. PMID: 11981087 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,223 results

Search Page

Filters